- ICH GCP
- Registro de ensayos clínicos de EE. UU.
- Ensayo clínico NCT03952000
Influence of Prior Walking on Postprandial Metabolism in Centrally Obese Men
Influence of Prior Walking on Endothelial Function and Coronary Heart Disease Risk Markers in Centrally Obese South Asian and White European Men
The present study will investigate the effect of prior walking on postprandial metabolism and endothelial function in centrally obese South Asian and White European men.
Participants will complete two, 2-day trials in a random, crossover design separated by at least a week.
On day 1, participants will either rest or complete a 60 minute walk at 60% maximal oxygen uptake. On day 2, participants will arrive at 08:00 having fasted overnight and a baseline venous blood sample and endothelial function measurement will be taken. Participants will consume a high-fat breakfast and lunch and 12 subsequent venous blood samples will be taken throughout the day at standardised intervals to measure a variety of coronary heart disease risk markers. A second endothelial function measurement will be completed 2 hours after the breakfast. Blood pressure will be measured every hour.
It is expected that the South Asian participants will have impaired metabolism and endothelial function compared to their European counterparts but the bout of exercise performed on day 1 will mitigate these responses.
Descripción general del estudio
Estado
Condiciones
Intervención / Tratamiento
Descripción detallada
South Asians have a higher-than-average risk of coronary heart disease. The reasons for this are unclear, but physical inactivity and/or poor responsiveness to exercise may play a role. It is important to understand the effect of exercise on endothelial function and coronary heart disease risk markers in the hope that exercise can be prescribed as an effective treatment to mitigate endothelial dysfunction and the risk of heart disease.
Previous research from the investigators' laboratory has indicated that postprandial metabolism is impaired in South Asian men, but this, and other coronary heart disease risk markers, can be improved with acute exercise. However, the previous research was conducted in apparently healthy South Asian and White European men. The investigators now wish to quantify and compare the coronary heart disease risk marker and endothelial function response to acute exercise in centrally obese South Asian and White European individuals who are at a higher risk for diabetes and cardiovascular disease.
On visit 1, participants will attend the laboratory to undergo preliminary assessments and to be familiarised with the laboratory environment and study procedures. Specifically, health status, habitual physical activity, dietary habits and anthropometric data (height, weight, waist and hip circumference, body fat) will be collected. A HbA1c test will be performed to check participants are not diabetic. The modified Bruce Treadmill test will be performed to predict maximal oxygen uptake.
On visit 2, participants will undergo a magnetic resonance imaging (MRI) scan to quantify regional body composition comprising abdominal subcutaneous adipose tissue, visceral adipose tissue, liver fat percentage, thigh intramuscular adipose tissue and thigh muscle volume.
On visits 3-6 participants will complete two, 2-day trials in a random, crossover design separated by at least 1 week. On day 1 of both trials, participants will arrive fasted at 08:00 and a baseline blood sample, blood pressure and endothelial function measurement will be taken. Participants will consume a standardised high fat breakfast at 09:00 and lunch at 13:00. At 15:30 the participants will walk for 60 minutes at 60% maximal oxygen uptake and complete a second endothelial function measurement at 16:45. Participants will leave the laboratory with a standardised evening meal to consume before 22:00. The control trial will be the same, except no exercise will be performed.
On day 2, participants will arrive at 08:00 having fasted overnight for 10h (except plain water). A cannula will be inserted into the antecubital vein for collection of venous blood samples. Blood pressure will be measured at 08:00 (0h) and again at hourly intervals throughout the day. Endothelial function will measured at 08:15 (0.25h) and again at 3h. At 0h, a fasting blood sample will be collected. Subsequent venous blood samples will be collected at 1.5, 1.75, 2, 3, 4, 5, 5.5, 5.75, 6, 7, 8 and 9h. Participants will consume a standardised high fat breakfast at 1h and a standardised high fat lunch at 5h. The meals consist of 57% fat, 32% carbohydrate and 11% protein. The meals provide 14.3 kcal per kg of body mass.
Participants will rest in the laboratory throughout day 2 of both the exercise and control trials.
Tipo de estudio
Inscripción (Actual)
Fase
- No aplica
Contactos y Ubicaciones
Ubicaciones de estudio
-
-
-
Loughborough, Reino Unido, LE11 3TU
- National Centre for Sport and Exercise Medicine, Loughborough University
-
-
Criterios de participación
Criterio de elegibilidad
Edades elegibles para estudiar
Acepta Voluntarios Saludables
Géneros elegibles para el estudio
Descripción
Inclusion Criteria:
- 18 to 60 year old South Asian and White European men;
- Centrally obese (waist circumference >90cm for South Asians, >94cm for White Europeans);
- Weight stable for the past 3 months;
- Non-smokers;
- No known contradictions to maximal exertion exercise.
Exclusion Criteria:
- Musculoskeletal injury that has affected normal ambulation within the last month;
- Congenital heart disease;
- Any muscle or bone injuries that do not allow them to walk on a treadmill;
- Uncontrolled exercise-induced asthma;
- Coagulation or bleeding disorders;
- Diabetes (metabolism will be different to non-diabetics potentially skewing the data);
- Taking any medication that might influence fat metabolism;
- Taking any medication that might influence blood glucose (e.g., insulin for diabetes);
- Heart conditions;
- Smoking;
- Dieting or restrained eating behaviours;
- Weight fluctuation greater than 3 kg in the previous 3 months to study enrolment;
- A food allergy.
Plan de estudios
¿Cómo está diseñado el estudio?
Detalles de diseño
- Propósito principal: Prevención
- Asignación: Aleatorizado
- Modelo Intervencionista: Asignación cruzada
- Enmascaramiento: Ninguno (etiqueta abierta)
Armas e Intervenciones
Grupo de participantes/brazo |
Intervención / Tratamiento |
|---|---|
|
Experimental: Experimental: Exercise
Exercise: Participants will walk for 60 minutes at 60% maximal oxygen uptake on day 1.
|
Una caminata de 60 minutos con un consumo máximo de oxígeno del 60 %.
|
|
Sin intervención: No Intervention: Control
Participants will rest on day 1.
|
¿Qué mide el estudio?
Medidas de resultado primarias
Medida de resultado |
Medida Descripción |
Periodo de tiempo |
|---|---|---|
|
Triacylglycerol changes in response to exercise and feeding
Periodo de tiempo: Day 1 fasting. Day 2 fasting (0 hour point), 1.5hours, 1.75hours, 2hours, 3hours, 4hours, 5hours, 5.5hours, 5.75hours, 6hours, 7hours, 8hours and 9hours.
|
Fasting on day 1 and 2. Time-course of plasma triacylglycerol concentrations in response to exercise and/or feeding on day 2.
|
Day 1 fasting. Day 2 fasting (0 hour point), 1.5hours, 1.75hours, 2hours, 3hours, 4hours, 5hours, 5.5hours, 5.75hours, 6hours, 7hours, 8hours and 9hours.
|
|
Endothelial function changes in response to exercise and feeding
Periodo de tiempo: Day 1 fasting and 8.75hours. Day 2 fasting and 2.5hours.
|
Changes in endothelial function via flow-mediated dilatation in response to feeding and exercise.
|
Day 1 fasting and 8.75hours. Day 2 fasting and 2.5hours.
|
Medidas de resultado secundarias
Medida de resultado |
Medida Descripción |
Periodo de tiempo |
|---|---|---|
|
Colesterol total
Periodo de tiempo: Día 1 ayuno. Día 2 ayuno.
|
Colesterol total en plasma en ayunas el día 1 y el día 2 de ambos ensayos.
|
Día 1 ayuno. Día 2 ayuno.
|
|
Colesterol de lipoproteínas de alta densidad
Periodo de tiempo: Día 1 ayuno. Día 2 ayuno.
|
Colesterol de lipoproteínas de alta densidad en ayunas los días 1 y 2 de ambos ensayos.
|
Día 1 ayuno. Día 2 ayuno.
|
|
Colesterol de lipoproteínas de baja densidad
Periodo de tiempo: Día 1 ayuno. Día 2 ayuno.
|
Colesterol de lipoproteínas de baja densidad en ayunas los días 1 y 2 de ambos ensayos.
|
Día 1 ayuno. Día 2 ayuno.
|
|
Glucose changes in response to exercise and/or feeding
Periodo de tiempo: Day 1 fasting. Day 2 fasting (0 hour point), 1.5hours, 1.75hours, 2hours, 3hours, 4hours, 5hours, 5.5hours, 5.75hours, 6hours, 7hours, 8hours and 9hours.
|
Fasting on day 1 and 2. Time-course of plasma glucose concentrations in response to exercise and/or feeding on day 2.
|
Day 1 fasting. Day 2 fasting (0 hour point), 1.5hours, 1.75hours, 2hours, 3hours, 4hours, 5hours, 5.5hours, 5.75hours, 6hours, 7hours, 8hours and 9hours.
|
|
Blood pressure changes in response to exercise and/or feeding
Periodo de tiempo: Day 1 fasting. Day 2 fasting (0 hour point) and 1hours, 2hours, 3hours, 4hours, 5hours, 6hours, 7hours, 8hours and 9hours.
|
Changes in blood pressure (systolic and diastolic).
|
Day 1 fasting. Day 2 fasting (0 hour point) and 1hours, 2hours, 3hours, 4hours, 5hours, 6hours, 7hours, 8hours and 9hours.
|
|
Insulin changes in response to exercise and/or feeding
Periodo de tiempo: Day 1 fasting. Day 2 fasting (0 hour point), 1.5hours, 2hours, 4hours, 5hours, 5.5hours, 7hours, 8hours.
|
Fasting on day 1 and 2. Time-course of plasma insulin concentrations in response to exercise and/or feeding on day 2.
|
Day 1 fasting. Day 2 fasting (0 hour point), 1.5hours, 2hours, 4hours, 5hours, 5.5hours, 7hours, 8hours.
|
|
Non-esterified fatty acids changes in response to exercise and/or feeding
Periodo de tiempo: Day 1 fasting. Day 2 fasting (0 hour point), 1.5hours, 2hours, 4hours, 5hours, 5.5hours, 7hours and 9hours.
|
Fasting on day 1 and 2. Time-course of plasma non-esterified fatty acid concentrations in response to exercise and/or feeding on day 2.
|
Day 1 fasting. Day 2 fasting (0 hour point), 1.5hours, 2hours, 4hours, 5hours, 5.5hours, 7hours and 9hours.
|
|
Interleukin-6 changes in response to exercise and/or feeding
Periodo de tiempo: Day 1 fasting. Day 2 fasting (0 hour point), 3hours, 6hours and 8hours.
|
Fasting on day 1 and 2. Time-course of plasma interleukin-6 concentrations in response to exercise and/or feeding on day 2.
|
Day 1 fasting. Day 2 fasting (0 hour point), 3hours, 6hours and 8hours.
|
|
C-Reactive protein changes in response to exercise and/or feeding
Periodo de tiempo: Day 1 fasting. Day 2 fasting (0 hour point), 3hours, 6hours and 8hours.
|
Fasting on day 1 and 2. Time-course of plasma C-Reactive protein concentrations in response to exercise and/or feeding on day 2.
|
Day 1 fasting. Day 2 fasting (0 hour point), 3hours, 6hours and 8hours.
|
|
Tumor Necrosis Factor concentrations
Periodo de tiempo: Day 1 fasting. Day 2 fasting.
|
Fasting tumor necrosis factor on day 1 and 2 of both trials.
|
Day 1 fasting. Day 2 fasting.
|
|
Peroxiredoxin-4 changes in response to exercise and/or feeding
Periodo de tiempo: Day 1 fasting. Day 2 fasting (0 hour point), 3hours, 6hours and 8hours.
|
Fasting on day 1 and 2. Time-course of plasma peroxiredoxin-4 concentrations across day 2 of both trials.
|
Day 1 fasting. Day 2 fasting (0 hour point), 3hours, 6hours and 8hours.
|
|
Superoxide dismutase 3
Periodo de tiempo: Day 1 fasting. Day 2 fasting (0 hour point), 3hours, 6hours and 8hours.
|
Fasting on day 1 and 2. Time-course of plasma Superoxide dismutase 3 concentrations across day 2 of both trials
|
Day 1 fasting. Day 2 fasting (0 hour point), 3hours, 6hours and 8hours.
|
Colaboradores e Investigadores
Patrocinador
Colaboradores
Publicaciones y enlaces útiles
Publicaciones Generales
- Arjunan SP, Deighton K, Bishop NC, King J, Reischak-Oliveira A, Rogan A, Sedgwick M, Thackray AE, Webb D, Stensel DJ. The effect of prior walking on coronary heart disease risk markers in South Asian and European men. Eur J Appl Physiol. 2015 Dec;115(12):2641-51. doi: 10.1007/s00421-015-3269-7. Epub 2015 Oct 5.
- Arjunan SP, Bishop NC, Reischak-Oliveira A, Stensel DJ. Exercise and coronary heart disease risk markers in South Asian and European men. Med Sci Sports Exerc. 2013 Jul;45(7):1261-8. doi: 10.1249/MSS.0b013e3182853ecf.
Fechas de registro del estudio
Fechas importantes del estudio
Inicio del estudio (Actual)
Finalización primaria (Actual)
Finalización del estudio (Actual)
Fechas de registro del estudio
Enviado por primera vez
Primero enviado que cumplió con los criterios de control de calidad
Publicado por primera vez (Actual)
Actualizaciones de registros de estudio
Última actualización publicada (Actual)
Última actualización enviada que cumplió con los criterios de control de calidad
Última verificación
Más información
Términos relacionados con este estudio
Términos MeSH relevantes adicionales
Otros números de identificación del estudio
- R18-P120
Plan de datos de participantes individuales (IPD)
¿Planea compartir datos de participantes individuales (IPD)?
Descripción del plan IPD
Marco de tiempo para compartir IPD
Criterios de acceso compartido de IPD
Tipo de información de apoyo para compartir IPD
- PROTOCOLO DE ESTUDIO
- SAVIA
- CIF
Información sobre medicamentos y dispositivos, documentos del estudio
Estudia un producto farmacéutico regulado por la FDA de EE. UU.
Estudia un producto de dispositivo regulado por la FDA de EE. UU.
Esta información se obtuvo directamente del sitio web clinicaltrials.gov sin cambios. Si tiene alguna solicitud para cambiar, eliminar o actualizar los detalles de su estudio, comuníquese con register@clinicaltrials.gov. Tan pronto como se implemente un cambio en clinicaltrials.gov, también se actualizará automáticamente en nuestro sitio web. .